Enteral Administration News
-
Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology
In a groundbreaking development in the field of pharmaceuticals, CD Formulation, a prominent drug formulation company, has announced the launch of Oral Thin Film Technology. This cutting-edge drug delivery system is poised to revolutionize medication administration, offering patients a more convenient and effective treatment method. Oral Thin Film Technology is a user-friendly drug delivery ...
-
Analysis of medical sterilization packaging bag
Disinfection and sterilization packaging can be divided into two parts: primary packaging and auxiliary packaging. Generally speaking, the disinfection and sterilization packaging of medical devices refers to the initial packaging of the product, that is, the part that directly contacts the product and forms a microbial barrier. Auxiliary packaging mainly involves the storage and circulation of ...
-
Soundbite Medical Enters Into A License Agreement With VFLO Medical To Bring Its Products To Greater China
Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that it has entered into an exclusive license agreement with VFLO Medical (VFLO). Pursuant to the agreement, Soundbite has granted to VFLO an exclusive license for certain proprietary ...
-
NEW: Interactive Winch Configurator Tool
InterOcean Systems launches a new online Winch Configurator tool. Allows users to enter their cable handling application requirements to generate a complete spooling chart, along with a cost estimator and horsepower estimator. New Winch Configurator tool can be found here: InterOcean Systems Winch Configurator ...
-
Cerevast Medical Enters Into Strategic Collaboration With Lantheus Medical Imaging for Retinal Vein Occlusion Treatment
Under a development and commercial supply agreement, Lantheus’ microbubble will be used in combination with Cerevast’s ocular ultrasound device to target improving blood flow in occluded retinal veins in the eye. Cerevast’s RVO Technology will combine intravenous administration of Lantheus’ microbubbles with non-invasive ultrasound delivered across the closed eyelid. By ...
-
Korea`s first long-term continuous wearable ECG monitor, enters the medical field.
‘ATP-C70’, wearable ECG monitor of ATsens starts prescribing at Sejong Chungnam National University Hospital. It’s an extension of the smart ward platform business and is introduced into Korea's first smart outpatient treatment program. It will support accurate vital sign measurement and customized diagnosis of arrhythmia patients through AT Patch, which can measure ECG for ...
-
Another good news for Deep01! Taiwan`s first AI product obtained marketing approval from Japan`s FDA
DeepCT - Intracranial Hemorrhage (ICH) AI Detection Software - developed by Taiwan's high-profile AI start-up team Deep01 - has obtained the marketing approval of Japan's PMDA, which is the first deep learning software officially licensed by Japan in Taiwan , marking a new milestone in Taiwan's AI medical output. Japan has the world's most aging population, and with advanced medical development, ...
-
ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill
MARTINEZ, Calif. – ExThera Medical and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for ExThera’s Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100). Per the agreement structure, ExThera Medical and Asahi Kasei Medical will collaborate to obtain regulatory approval of Seraph 100 ...
-
Icecure Medical enters into an exclusive agreement in Poland for distribution of the Prosense Cryoablation System
IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that it has entered into an initial distribution agreement with Mobile SCANMED Systems SP. z o.o. (“Mobile SCANMED Systems”) to exclusively sell the ...
-
MV BioTherapeutics to present at 5th Microbiome Movement - Drug Development Europe
We are happy to announce that Fabio Grassi (MV BioTherapeutics founder) has been invited to contribute to the 5th Microbiome Movement – Drug Development Summit Europe 2021 being held virtually during January 27th-29th, 2021. The presentation has been included in the morning stream titled “Introducing the Era of Engineered Microbes” the 29th at 11.35. Leveraging Gut Microbiota ...
-
CoapTech Awarded $1.6 Million from NIH for Pediatric Feeding Tube Placement Device
CoapTech Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded CoapTech a two-year, $1.6M R44 Small Business Innovation Research (SBIR) Phase II grant on September 22, 2020 to finalize development of and trial its Pediatric PUMA-G System. This new grant builds on a prior $225,000 Phase I SBIR ...
By CoapTech
-
Backed by $18 Million and a Nationwide Agreement With One of the Largest Private Hospital Networks in The U.S., ENvizion® Unveils Enteral Feeding Tube ‘GPS’ Tech
ENvizion®, the FDA 510(k) cleared leader in enteral feeding placement navigation technology, announces its agreement with one of the largest private hospital networks in the U.S., with more than one hundred hospitals, to provide ENvizion’s feeding tube placement navigation devices nationwide. The company’s endeavor is backed by $18 million in investment. Key investors include ...
-
Succesfull Bio Digital 2020
MV BioTherapeutics participated for the first time to the international event Bio Digital 2020 presenting the company, the pipeline to over 50 companies. “We weren’t sure about the potential success when we applied to the Swiss Pavillon with the sponsoring of Innosuisse” confirms Dr. Fabio Grassi, founder and chairman. “The support we got from Switzerland Global ...
-
Surgeon Explains How MarginProbe® Protects Cosmetic Outcomes While Preventing Re-excision in Breast Conserving Surgery
Dr. Kerry-Ann McDonald, a breast surgeon at Boca Raton Regional Hospital in Boca Raton, Florida, credits her interest in medicine to her early days as a hospital volunteer. After entering the medical field and beginning residency, her path to becoming a surgeon was clear. “I always knew I wanted to be a surgeon because of the satisfaction that comes with helping others, and the immediate ...
-
Cerevast Medical Enters Into Strategic Collaboration With Lantheus Medical Imaging for Retinal Vein Occlusion Treatment
Under a development and commercial supply agreement, Lantheus’ microbubble will be used in combination with Cerevast’s ocular ultrasound device to target improving blood flow in occluded retinal veins in the eye. Cerevast’s RVO Technology will combine intravenous administration of Lantheus’ microbubbles with non-invasive ultrasound delivered across the closed eyelid. By ...
-
AVRA Medical Robotics, Inc. updates shareholders and the investment community with respect to recent events raising AVRA’s visibility in the medical robotics field
ORLANDO, Fla., Sept. 21, 2017 (GLOBE NEWSWIRE) — AVRA Medical Robotics, Inc. (“AVRA”), which is planning to enter the field of medical robotics through the development of an intelligent medical robotic system for skin resurfacing procedures in partnership with the University of Central Florida, today updated its shareholders and the investment community with respect to a ...
-
SurgiMab and Quest Medical Imaging announce Collaboration Agreement for phase III Clinical Trial
SurgiMab and Quest Medical Imaging, a leader in the market for multispectral cameras, announced today that they have entered into a collaboration agreement for the upcoming Phase III clinical trial of Surgimab’s SGM-101 in fluorescent guided colorectal cancer surgery. Under the terms of the agreement, Quest Medical Imaging has received an undisclosed lump sum payment to provide 12 ...
By SurgiMab
-
Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis
Clinical data showed superior efficacy & similar safety of MM-II vs. standard of care (hyaluronic acid) for treatment of pain in osteoarthritis Sun Pharma to fund further development of MM-II including completion of Phase 2 and Phase 3 clinical programs and any required preclinical work necessary for regulatory approval Sun Pharma has worldwide commercialization & manufacturing rights ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you